James Hunter, MBA
Executive Vice President, Commercial Operations
James Hunter joined the company as Executive Vice President of Commercial Operations at Tonix Pharmaceuticals and President of Tonix Medicines in June 2023. In this role, Mr. Hunter is responsible for leading all aspects of Tonix’s commercial efforts, including marketing strategy and promotion, sales force and supply chain management, managed care and government contracting and distribution.
Mr. Hunter brings to Tonix many years of experience as a leader in the biopharmaceutical industry. Mr. Hunter was CEO and Co-founder of Validus Pharmaceuticals from 2007 to 2018, where he was responsible for multiple successful product acquisitions from companies such as Shire, Roche, Novartis and Sanofi. Before co-founding Validus, Mr. Hunter was Executive Director of Neuroscience Sales at Novartis Pharmaceuticals, where he launched and supported products in schizophrenia, epilepsy, migraine, Parkinson’s and Alzheimer’s. Previously, Mr. Hunter served as Executive Director of the Northeast Business Unit at Ciba Geigy Pharmaceuticals, where he was responsible for the General Practice and hospital sales force and Regional Managed Care.
Mr. Hunter received his B.S. at Seton Hall University and earned his M.B.A at Fairleigh Dickinson University.